<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02069067</url>
  </required_header>
  <id_info>
    <org_study_id>Break-1</org_study_id>
    <nct_id>NCT02069067</nct_id>
  </id_info>
  <brief_title>Observational Study of Incidence of Breakthrough Cancer Pain and How it is Treated</brief_title>
  <acronym>Break-1</acronym>
  <official_title>Multicenter Observational Study of the Incidence and Treatment Modalities of Breakthrough Cancer Pain in Patients With Chronic Cancer Pain</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Cancer Institute, Naples</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Cancer Institute, Naples</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to describe how often advanced cancer patients experience
      breakthrough pain (BTcP), and to describe how this pain is treated, and how effective these
      treatments are.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>December 2011</start_date>
  <completion_date type="Anticipated">September 2017</completion_date>
  <primary_completion_date type="Anticipated">September 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>number of patients who experience BTcP</measure>
    <time_frame>one year</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>treatments used to treat BTcP</measure>
    <time_frame>one year</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>pain intensity</measure>
    <time_frame>4 weeks</time_frame>
    <description>evaluate the relationship between pain intensity, patient characteristics, and clinician choice of pain medication</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>time to pain relief of BTcP</measure>
    <time_frame>4 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>initial dose of therapy (in morphine equivalents) for BTcP</measure>
    <time_frame>4 weeks</time_frame>
    <description>to verify a correlation between initial dose for BTcP and daily dose of baseline pain therapy</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>effective dose for BTcP</measure>
    <time_frame>4 weeks</time_frame>
    <description>to verify a correlation between effective dose for BTcP and daily dose of baseline pain therapy (dose reported in morphine equivalents)</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">500</enrollment>
  <condition>Advanced Cancer</condition>
  <arm_group>
    <arm_group_label>Advanced cancer patients with pain</arm_group_label>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with advanced cancer and chronic pain being controlled with opiods.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Diagnosis of neoplasm in advanced stage

          -  Chronic pain controlled for at least one week with opioids 60 mg / day morphine
             equivalent

          -  1-6 episodes of BTcP within any of 3 days previous to registration into study

          -  Signed Informed Consent

        Exclusion Criteria:

        · More than 6 episodes of BTcP within any of 3 days previous to registration into study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Arturo Cuomo, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>NCI Naples, Division of Pain Therapy</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Francesco Perrone, M.D., Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>NCI Naples, Clinical Trials Unit</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Francesco Perrone, M.D., Ph.D.</last_name>
    <phone>+390815903571</phone>
    <email>francesco.perrone@usc-intnapoli.net</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Maria Carmela Piccirillo, M.D.</last_name>
    <phone>+390815903631</phone>
    <email>marina.piccirillo@usc-intnapoli.lnet</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Ospedale San Leonardo</name>
      <address>
        <city>Castellammare di Stabia</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Istituto Nazionale dei Tumori , Unita Terapia Antalgica</name>
      <address>
        <city>Napoli</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>S. Maria della Pietà</name>
      <address>
        <city>Nola</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>March 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 20, 2014</study_first_submitted>
  <study_first_submitted_qc>February 20, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 21, 2014</study_first_posted>
  <last_update_submitted>March 28, 2017</last_update_submitted>
  <last_update_submitted_qc>March 28, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">March 29, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>breakthrough cancer pain</keyword>
  <keyword>pain</keyword>
  <keyword>neuropathic pain</keyword>
  <keyword>intractable pain</keyword>
  <keyword>cancer</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cancer Pain</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

